Xcout IntelSign inSubscribe

DeVoro Medical Inc. competitors & alternatives

Medical Devices & PublishingUnited States

The 12 closest competitors and alternatives to DeVoro Medical Inc. among medical devices & publishing companies — ranked by similarity to what DeVoro Medical Inc. actually does, not by market-cap band.

12Competitors listed

Subscribe to see DeVoro Medical Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About DeVoro Medical Inc.

Devoro Medical, Inc. is a medical device company developing a mechanical thrombectomy platform for peripheral interventions. The company has received strategic investment from Marlborough, Massachusetts-based Boston Scientific, which announced an agreement to acquire Devoro Medical.

DeVoro Medical Inc. at a glance

DeVoro Medical Inc. is a medical devices & publishing company headquartered in United States. It has raised at least $32M across the 3 funding rounds on record. Its most recent funding round, Series A, raised $5.5M in December 2021. Xcout tracks 1 named person at DeVoro Medical Inc., including Mary Ann Cooke (Vice President, Life Sciences).

DeVoro Medical Inc. leadership

  • Mary Ann CookeVice President, Life Sciences

DeVoro Medical Inc. funding rounds

At least $32M raised across the 3 rounds on record. Every round on record:

DateRoundAmountInvestors
Series A$5.5M1 named
SEC Form D filing$18M—
SEC Form D filing$8.5M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 DeVoro Medical Inc. competitors

Ranked by semantic similarity — how close each company is to DeVoro Medical Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Boston Scientific0HOY · Medical DevicesMarlborough, United States
73% matchPublic

Medical Devices

Boston Scientific Corporation operates as a global medical technology firm, specializing in the design, production, and worldwide distribution of innovative medical devices tailored for various interventional specialties. The company's operations are strategically divided into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Through its MedSurg division, Boston Scientific provides critical diagnostic and therapeutic tools aimed at addressing conditions affecting the gastrointestinal and pulmonary systems, alongside a diverse portfolio of solutions for urological and pelvic health issues. The Rhythm and Neuro segment is dedicated to advanced cardiac rhythm management and neurological interventions. Its product offerings encompass implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT) defibrillators, and pacemakers (including CRT pacemakers), all complemented by remote patient monitoring platforms. This segment also delivers sophisticated technologies for assessing and treating cardiac rate and rhythm irregularities, featuring solutions such as 3-D mapping and navigation systems, various ablation and diagnostic catheters, intracardiac ultrasound catheters, and related accessories. In the neurological domain, it furnishes spinal cord stimulator systems for managing chronic pain, indirect decompression systems, and deep brain stimulation systems. Boston Scientific's Cardiovascular segment presents an extensive array of products focused on heart and vascular health. This includes cutting-edge interventional cardiology solutions like drug-eluting coronary stent systems for treating coronary artery disease, as well as percutaneous coronary intervention (PCI) instruments designed to tackle atherosclerosis. The segment further provides intravascular catheter-directed ultrasound imaging and fractional flow reserve (FFR) devices, applicable in coronary arteries, heart chambers, and peripheral vessels, in addition to structural heart therapies. Beyond this, the company supplies stents, balloon catheters, wires, and atherectomy systems for arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents for venous conditions; and a comprehensive suite of products for cancer treatment, including peripheral embolization devices, radioactive microspheres, various ablation systems (such as cryotherapy), and micro/drainage catheters. Established in 1979, the corporation maintains its headquarters in Marlborough, Massachusetts.

Market cap$65.2B
Employees59,000
Boston Scientific competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of DeVoro Medical Inc. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for DeVoro Medical Inc.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →